Burnouf, Thierry http://orcid.org/0000-0002-0507-9243
Chou, Ming-Li http://orcid.org/0000-0002-6996-5332
Lundy, David J. http://orcid.org/0000-0003-0848-3206
Chuang, Er-Yuan http://orcid.org/0000-0002-1593-4573
Tseng, Ching-Li http://orcid.org/0000-0001-9446-4030
Goubran, Hadi http://orcid.org/0000-0003-1201-7275
Funding for this research was provided by:
National Health Research Institutes (NHRI-EX111-10920E, NHRI-EX110-10920EI, NHRI-EX109-10920EI)
Ministry of Science and Technology, Taiwan (111-2314-B-038-025, 112-2923-E-038-001)
Article History
Received: 6 March 2023
Accepted: 23 August 2023
First Online: 14 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: TB is the inventor of patents owned by Taipei Medical University and is a founder of Invenis Biotherapies, a start-up company that develops applications of platelet lysates for brain administration and treatment of neurological disorders.